Clinical trial
A Study of the Effectiveness and Safety of Topiramate for the Prevention of…
NCT00210535 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00210535 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for the Prophylaxis of Migraine in Pediatric Subjects 12 to 17 Years of Age |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine, Vascular Headaches |
| Intervention type | Drug |
| Interventions | Topiramate, Placebo |
| Enrollment | 110 |
| Start date | Jun 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: